Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Stock Traders Daily
$20.00
Provider: ValuEngine, Inc.
$49.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Cross Country Healthcare Inc Announces Completion Of Sale Of Clinical Trial Services Business To ICON plc


Tuesday, 19 Feb 2013 06:00am EST 

Cross Country Healthcare Inc announced it has completed the previously announced sale of its clinical trial services business to ICON plc for $52 million, plus an earn-out of up to $3.75 million related to certain performance-based milestones. Cross Country Healthcare used a portion of the net proceeds from this transaction to repay all $29.3 million of its outstanding bank debt. 

Company Quote

10.24
0.15 +1.49%
1:03pm EST